Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia.

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Abstract Text:

Aim: A low platelet count leads to dose reduction of interferon (IFN) and is associated with failure to achieve a sustained virological response (SVR) in chronic hepatitis C patients. However, partial splenic embolization (PSE) is effective for treating thrombocytopenia resulting from hypersplenism. Methods: We compared the clinical features of 10 patients receiving PSE prior to the combination therapy of IFN and ribavirin (RBV) (PSE group) with those of 10 non-receiving PSE patients (non-PSE group). Results: In all 10 patients, PSE was successfully performed without serious adverse events. After PSE, leukocyte, neutrophil, and platelet counts significantly increased. The period from PSE to the initiation of the combination therapy was 15 (7-21) days. In the PSE group, two of six patients (33%) infected with genotype 1, and all four patients infected with genotype 2, achieved SVR. In the non-PSE group, only three patients infected with genotype 2 achieved SVR. Two patients in the PSE group and one in the non-PSE group discontinued the combination therapy. Three patients of the PSE group and five of the non-PSE group reduced the dose of pegylated IFN-alpha-2b because of thrombocytopenia. In the PSE group, platelet counts during the combination therapy fell to baseline levels; however, they did not fall to lower levels than baseline levels. In the non-PSE group, platelet counts 1 month after the initiation of the therapy were lower than baseline levels. Conclusion: The increase of platelet counts after PSE may allow the safe use of IFN and RBV and improve the SVR rate in chronic hepatitis C patients with thrombocytopenia.

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hepatology research : the official journal of the

VOLUME: 38

Page Numbers: 980-6

Journal Abbreviation: Hepatol. Res.

ISSN: 1386-6346

DAY: 24

MONTH: 07

YEAR: 2008

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9711801

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia.

AFFILIATION: Department of Internal Medicine, Mitoyo General Hospital, Kagawa, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia Related Publications

• A metastatic adenocarcinoma of lung simulating humeral head osteonecrosis.
• Anatomical study on the menisco-femoral ligaments of the knee.
• Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
• Bone and joint lesions associated with pustulosis palmaris et plantaris. A clinical and histological study.
• Bone cell activities and calcium-regulating hormones.
• Correct citation regarding interleukin-6 levels in cerebrospinal fluid from patients with neuropsychiatric lupus: comment on the article by Fragoso-Loyo et al.
• Decreased numbers of T gamma lymphocytes in rheumatoid synovial membrane.
• Distribution of neural elements in collateral ligaments of the rat knee joint--light and electron microscopic studies using silver impregnation method and cholinesterase histochemistry.
• Dumbbell-shaped spinal extradural hemangioma.
• EMG biofeedback in tendon transplantation for foot drop.
• Effect of intramedullary bone cement fixation on fracture healing.
• Enhanced Production of IgE Anti-Japanese Cedar Pollen Specific Antibodies by Peripheral Blood B Cells from Patients with Japanese Cedar Pollinosis.
• Genu recurvatum: a complication of prolonged femoral skeletal traction.
• Histopathology of central nervous system lesions in Behçet's disease.
• Interaction of macrophages with rheumatoid articular cartilage.
• Light microscopic and electron microscopic studies of individual cells in pigmented villonodular synovitis and bursitis (Jaffé).
• Osteogenic potential of hematoma in fracture healing--transplantation of hematoma under the periosteum of the parietal bone.
• Partial splenic embolization prior to combination therapy of interferon and ribavirin in chronic hepatitis C patients with thrombocytopenia.
• Peroneal nerve palsy due to fabella.
• Studies on bromelain. II. Its activation and fractionation.
• The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma.
• The response of osteocytes to a lipid clearing agent in steroid-treated rabbits.
• Vertebral compression fracture following segmental spinal instrumentation.
• Weakness of thigh muscles in individuals sustaining anterior cruciate ligament injury.